Cheng Lin

发表

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma

Bin Zhang, Jianji Pan, J. Zong, 2022, The oncologist.

Circular RNA LONP2 regulates proliferation, invasion, and apoptosis of bladder cancer cells by sponging microRNA-584-5p

Yong Zhao, Cheng Lin, Xu Zhang, 2022, Bioengineered.

Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma

Jianji Pan, J. Zong, Shaojun Lin, 2021, Head & neck.

Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.

B. O'Sullivan, V. Lee, K. Lam, 2022, Oral oncology.

CENPU Promotes Growth and Metastasis in Nasopharyngeal Carcinoma by Inhibiting DUSP6

Jianji Pan, J. Zong, Cheng Lin, 2021 .

Circulating Epstein‐Barr virus microRNAs BART7‐3p and BART13‐3p as novel biomarkers in nasopharyngeal carcinoma

Jianji Pan, J. Zong, Shaojun Lin, 2020, Cancer science.

RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma

J. Zong, Cheng Lin, Y. Ye, 2022, BMC cancer.

Systemic immune-inflammation index as a prognostic marker in patients with newly diagnosed metastatic nasopharyngeal carcinoma: a propensity score-matched study

Sheng Lin, Jianji Pan, J. Zong, 2019, Translational cancer research.

Diagnostic and prognostic performance of circulating levels of the Epstein-Barr virus microRNAs BART 7-3p and BART 13-3p in nasopharyngeal carcinoma

Jianji Pan, J. Zong, Shaojun Lin, 2020 .

Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma.

Jianji Pan, J. Zong, Shaojun Lin, 2022, Oral oncology.

Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis

Sheng Lin, Jianji Pan, Cheng Lin, 2021, BMC cancer.

Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression

Wei Zheng, Xiong Chen, Cheng Lin, 2014, Cancer science.

Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity‐modulated radiotherapy era

Jianji Pan, J. Zong, Shaojun Lin, 2019, Head & neck.

Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.

J. Zong, Shaojun Lin, Yuanji Xu, 2019, Cancer letters.

EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways

Bin Zhang, Jianji Pan, J. Zong, 2018, Journal of experimental & clinical cancer research : CR.

EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways

Bin Zhang, Jianji Pan, J. Zong, 2018, Journal of Experimental & Clinical Cancer Research.

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma

Jianji Pan, J. Zong, Shaojun Lin, 2023, BMC Genomics.

Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways

Bin Zhang, Jianji Pan, J. Zong, 2019, Journal of Experimental & Clinical Cancer Research.

Individualized Concurrent Chemotherapy for Patients with Stage III–IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy

J. Zong, Shaojun Lin, Cheng Lin, 2023, Cancer research and treatment.